- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06209216
Twenty-Four Seven Functional Status in Total Hip Replacement (LEARNT)
An Observational Study to Explore Twenty-Four Seven Functional Status Measures in Total Hip Replacement (LEARNT)
Study Overview
Status
Conditions
Detailed Description
Approximately 25 participants will be enrolled in this study. The study consists of a 1-week Screening period, a 1-week Baseline period, up to 6-week assessment period (post-surgery), and an end of participation (EOP) visit. With the exception of in clinic visits at the beginning and end of study, this observational study will leverage fully remote data capture.
The categories of functional status and corresponding measures captured in this study include:
- Physical activity and mobility, with outcome measures including hourly and daily step count, gait speed, and metabolic equivalent of task.
- Vital signs, with outcome measures including heart rate, heart rate variability and blood pressure.
- Sleep concept, with outcome measures including sleep duration, sleep quality, sleepiness and sleep timing.
- HRQoL captured using validated instruments and diaries via electronic patient reported outcomes (ePRO) platforms, assessing aspects of health that are meaningful to individual's hip replacement such as disease- and treatment-related symptoms and the impact their physical health may have on activities of daily living, their work life, and socializing.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Koneksa Health
- Phone Number: 551-866-0025
- Email: KH009@koneksahealth.com
Study Locations
-
-
Florida
-
The Villages, Florida, United States, 32159
- Recruiting
- Premier Medical Associates
-
Contact:
- Lori Dameron
- Phone Number: 407-701-0332
- Email: ldameron@vantagetrials.com
-
Contact:
- Paige A Deckard, LPN
- Phone Number: 407-701-0332
- Email: pdeckard@vantagetrials.com
-
Principal Investigator:
- Sanjay B Shah, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants diagnosed with osteoarthritis of the hip or degenerative joint disease and have decided to undergo total hip arthroplasty
- Patients willing to sign the informed consent form
- Age 30 and older
- Demonstrated ability to perform satisfactory at-home assessments as well as the mobile application to synchronize data collection and respond to questionnaires during the screening period
Exclusion Criteria:
- Participants with clinically unstable serious diseases (e.g., heart or lung disease) that would deem them unfit for the study in the Investigator's opinion
- Secondary total hip replacement on the same side
- Hip replacement for neoplasm, proximal femoral fracture, or other causes than osteoarthritis
- Contemporary bilateral replacement
- History of substance abuse in the last 6 months, excluding medical or recreational non-inhaled marijuana
- Current cancer
- Presence of neurological diseases previous to and/or following surgery (peripheral neuropathy is generally acceptable)
- Congenital abnormalities
- Patients with active infection within last 30 days
- Psychotropic drugs except for pain management and antidepressants
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Total Hip Replacement
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Hip Assessment - In Clinic
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Harris Hip Score
|
Baseline Day 1 through Day 42 End of Participation
|
Mobile Vital Signs via Mobile Blood Pressure Cuff
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Orthostatic blood pressure
|
Baseline Day 1 through Day 42 End of Participation
|
Daily Measurements via Wrist-worn Device
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Heart rate variability, body temperature, step count, blood oxygen saturation
|
Baseline Day 1 through Day 42 End of Participation
|
Objective Measures of Sleep via Wrist-worn Device
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Sleep staging measured by a combination of heart rate variability + actigraphy + blood oxygen saturation and vital signs during sleep
|
Baseline Day 1 through Day 42 End of Participation
|
Motor Function Assessments via Koneksa Application
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Gait (20 second walk test)
|
Baseline Day 1 through Day 42 End of Participation
|
Participant Diary via Koneksa Application
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Pain level likert scale, pain medication use, walking aid use
|
Baseline Day 1 through Day 42 End of Participation
|
Sleep Electronic Patient Reported Outcomes
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Sleep Diary and Stanford Sleepiness Scale
|
Baseline Day 1 through Day 42 End of Participation
|
Quality of Life Patient Reported Questionnaire Scores
Time Frame: Baseline Day 1 through Day 42 End of Participation
|
Instrumental Activities of Daily Living Scale, PHQ-9 for Depression Score, Functional Assessment of Chronic Illness Therapy - Fatigue (PROMIS SF v1.0 Fatigue 13a) Score, Brief Pain Inventory Short Form for Pain Score
|
Baseline Day 1 through Day 42 End of Participation
|
Additional Questionnaire via Koneksa Platform
Time Frame: Baseline Day 1 through Day 365 End of Participation
|
Usability for devices and app-based study-specific assessments questionnaire, questionnaires for site clinical care team likelihood to recommend all devices used, and app-based assessments, questionnaires for understanding of tasks and assessment of meaningfulness, participant and/or caregiver likelihood to recommend, ease of use and satisfaction
|
Baseline Day 1 through Day 365 End of Participation
|
Clinician Reported Adverse Events
Time Frame: Baseline Day 1 through Day 365 End of Participation
|
Clinical event defined as event requiring medical intervention from call to doctor or emergency room services (such as fall)
|
Baseline Day 1 through Day 365 End of Participation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KH009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Replacement
-
National Taiwan University HospitalUnknownTotal Hip Replacement | Total Hip ArthroplastyTaiwan
-
The Royal Bournemouth HospitalCompletedArthroplasty, Replacement, Hip | Hip Replacement, TotalUnited Kingdom
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical AssociationCompletedTotal Hip Replacement | Total Knee ReplacementCanada
-
Ortho Development CorporationOregon Health and Science UniversityEnrolling by invitationTotal Hip Replacement | Total Hip ArthroplastyUnited States
-
Mayo ClinicCompletedKnee Total Joint Replacement | Hip Total Joint ReplacementUnited States
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
-
Second Hospital of Shanxi Medical UniversityRecruitingTotal Hip ReplacementChina
-
Medacta International SASuspended
-
EgymedicalpediaOctober 6 UniversityCompletedTotal Hip ReplacementEgypt
-
Mayo ClinicCompletedTotal Hip ReplacementUnited States